SharePoint
A- A A+

For Patients & Visitors

Find a Doctor

Find a Doctor

Dr Robin Cherian

Designations:
  • Consultant, Department of Cardiology, National University Heart Centre, Singapore
  • Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore
Qualifications:
MBBS (India), MRCP (UK)
Specialties:
Cardiology (Heart)
Sub-Specialties:
Cardiac Critical Care, Cardiac Imaging (Nuclear Cardiology), Coronary Heart Disease, General Cardiology, Heart Failure
Special Interests:
Critical Care Cardiology, Valvular Heart Disease, Heart Failure, Cardiac Imaging, COVID-19 and the heart

Biosketch

Assistant Professor Robin Cherian graduated with the degrees of Bachelor of Medicine and Surgery from JIPMER, India in 2007. He completed his Basic Specialist Training in Internal Medicine in Singapore, and was conferred Membership of the Royal College of Physicians (United Kingdom) in 2012. Thereafter, he completed Advanced Specialist Training in Cardiology in 2016. He is currently a Consultant with the Department of Cardiology at the National University Heart Centre, Singapore (NUHCS).

He completed his advanced clinical fellowship in critical care cardiology at Royal Papworth Hospital NHS trust, Cambridge, UK. His research interests include critical care cardiology, echocardiography and valvular heart disease.

Asst Prof Cherian is also active in undergraduate and postgraduate medical education. He is a core faculty member of the Cardiology Senior Residency Program and an Assistant Professor with the Yong Loo Lin School of Medicine, National University of Singapore.

Awards

  • ​2018- AMDA to undergo critical care training at Royal Papworth Hospital, UK

Journals & Publications

  1. Cherian R. Clinical risk stratification in COVID-19: the need for a revised approach? Pulm Circ. 2021;11:204589402098863.
  2. Cherian R, Chandra B, Tung ML, Vuylsteke A. Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intrapulmonary Shunts in Response to Microvascular Occlusion. Am J Respir Crit Care Med. 2021;203:263–265.
  3. Cherian R, Chandra B, Tung ML, Vuylsteke A. COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness. Eur Respir J. 2020;56:2002135.
  4. Low T-T, Cherian R, Lim SL, Chandra B, Tung ML, Kumar SK, Lye P, Chin Xin Yi A, Teo L, Tay EL-W. Rethinking COVID-19 'pneumonia' – is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine? Pulm Circ. 2020;10:204589402093170.
  5. Cherian R, Poh K. At the 'heart' of the COVID-19 outbreak: early cardiac implications and mitigating strategies. smedj. 2020;61:373–374.
  6. Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatology Advances in Practice. 2021;5:rkaa081.
  7. Lin W, Cherian R, Kang GS, Tan HC, Low AF. Catheter-Based Left Ventricular Assist Device for the Management ofCardiogenic Shock Complicating Acute Myocardial Infarction: A First-in-Singapore Experience. Ann Acad Med Singap. 2020;49:707–711.
  8. Yeo LLL, Andersson T, Yee KW, Tan BYQ, Paliwal P, Gopinathan A, Nadarajah M, Ting E, Teoh HL, Cherian R, Lundström E, Tay ELW, Sharma VK. Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first? J Thromb Thrombolysis. 2017;44:104–111.

Professional Memberships

  • 2012- ​Royal College of Physicians, United Kingdom